Once-Weekly Insulin Icodec Arrives for Type 2 Diabetes

October 2026

Insulin icodec (Awiqli) will be the first once-WEEKLY U-700 insulin.

Think of it as an ultra-long-acting basal insulin.

Icodec’s half-life is about a week, mainly due to binding albumin in the bloodstream...making a “depot” that slowly releases insulin.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote